March 2023 in “International Journal of Advanced Research in Science, Communication and Technology” This article discusses various synthetic and herbal treatments for alopecia, noting limited effectiveness and associated side effects of synthetic options, and reports no new clinical results.
1 citations
,
October 2022 in “PubMed” This abstract describes androgenetic alopecia, a common dermatological condition, and does not provide new clinical findings.
1 citations
,
September 2022 in “Journal of The American Academy of Dermatology” In this analysis of two trials, baricitinib showed eyebrow and eyelash regrowth in severe alopecia areata patients with greater than 20% scalp hair loss at Week 36, compared to placebo.
3 citations
,
May 2020 in “Journal of The Korean Medical Association” This review discusses treatment options for androgenetic alopecia, with a focus on the better efficacy of oral finasteride and dutasteride over topical minoxidil for male pattern hair loss, but it reports no new clinical results.
July 2013 in “DeckerMed Medicine” This review discusses various types of hair loss, including androgenetic alopecia, telogen effluvium, and alopecia areata, and reports no new experimental findings.
July 2013 in “DeckerMed Family Medicine” This review discusses various types of alopecia, including androgenetic, diffuse, and cicatricial, along with their diagnosis and treatment, and reports no new experimental findings.
75 citations
,
December 2011 in “British Journal of Dermatology” This review discusses female pattern hair loss, its psychological impact, and available treatments but provides no new clinical findings; the authors emphasize early intervention for better outcomes.
36 citations
,
August 2009 in “PubMed” This article discusses different types of hair loss, their potential causes, and treatment options, but it reports no new clinical findings; the authors emphasize the importance of considering the emotional impact on patients.
January 2008 in “Journal of Clinical Dermatology” This study found that a new topical agent, Scalp medⓇ, significantly improved hair count and thickness in men with androgenetic alopecia after 24 weeks of treatment.
72 citations
,
January 2001 in “Drugs” This review discusses current and emerging drug therapies for treating androgenetic alopecia and alopecia areata, and reports no clinical results; it highlights a need for improved and novel treatments.
